HealthSource vs Hers
HealthSource and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between HealthSource and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. HealthSource leads our six-part score, 7.7 to 6.6. One of the two has an FDA warning letter on record, covered below.
HealthSource vs Hers price
HealthSource and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.
Medications and formats
Both sell semaglutide and tirzepatide.
On format, HealthSource prices compounded injections, while Hers prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
HealthSource lists 50 states, and Hers lists 50 states.
They overlap in 50 states.
Pricing
HealthSource
From $199.00 every 4 weeks for compounded semaglutide with B12, in vials with syringes and alcohol pads. $199 is the entry tier; others are Full Dose, Starter 4-week, Starter 6-week and 8-week.
From $299.00 every 4 weeks for injectable tirzepatide, dispensed by a 503A partner pharmacy. Several dose tiers are offered; $299 is the entry tier.
From $399.00 every 4 weeks for a sublingual tirzepatide tablet taken once daily before bed. Ships in 5–10 business days. $399 is the entry tier.
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
HealthSource's price also covers the clinician visit and shipping, which Hers does not claim.
HealthSource is silent on lab work and coaching.
Hers is silent on shipping and lab work.
HealthSource
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, HealthSource scores 7.7 and Hers 6.6 out of 10.
HealthSource is stronger on value (4.5 vs 3.0), trust & safety (7.5 vs 5.5) and support (7.0 vs 3.0).
Effectiveness, user experience and accessibility are within half a point.
HealthSource
7.7/10
Hers
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.
HealthSource has no FDA warning letter on record with us.
Features & Coverage
| Feature | HealthSource | Hers |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | ✓8 features | 2 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About HealthSource
Semaglutide starts at $199/month. One subscription price buys the medication itself, the supplies, unlimited provider messaging over a HIPAA-compliant platform, and a telehealth visit with a physician who is board-certified. HealthSource sells compounded semaglutide and tirzepatide in two forms, injectable and oral sublingual, dispensed by a partner pharmacy that is US-based and FDA 503A licensed. All 50 US states are served, and direct-to-door delivery takes 3-5 business days.
Read our full HealthSource review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
HealthSource
What we like
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to HealthSource
Watch-outs
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
HealthSource wins this one, 7.7 to 6.6, above all for an oral route if you will not self-inject. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose HealthSource if…
You want an oral route if you will not self-inject and an opening price near $199 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →HealthSource vs Hers: FAQ
Close alternatives to HealthSource and Hers
- HealthSource vs Hims
- HealthSource vs Curex
- HealthSource vs HumeCare+
- Hers vs Hims
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.